Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
US OptionsDetailed Quotes
ABBV250502C138000
- 0.00
- 0.000.00%
15min DelayClose Apr 28 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest138.00Strike Price0.00Turnover0.00%IV-28.25%PremiumMay 2, 2025Expiry Date54.34Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AbbVie Newsroom
AbbVie Is Maintained at Buy by Guggenheim
Today's Analyst Rating | UBS Cuts Its Price Target Cut on Amazon to $253, Meta Platforms Price Target Raised to $695 by Loop Capital
Abbvie: FDA Approves RINVOQ, 15 Mg, Once Daily, For Treatment Of Adults With Giant Cell Arteritis
Express News | Rinvoq® (Upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (Gca)
Express News | Abbvie : Guggenheim Raises Target Price to $216 From $214
Warren Buffett's 60-Year Legacy: What to Watch for at Berkshire Hathaway Shareholders Meeting?
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ironwood Pharma (IRWD), AbbVie (ABBV) and Molecular Partners (MOLN)
RINVOQ (Upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
Why AbbVie Stock Trounced the Market Today
S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report
AbbVie Inc. Stock Rallies 3.4%, Outperforms Competitors
Equity Markets Mixed Before Key Earnings, Macro Data
AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst
AbbVie's Options Frenzy: What You Need to Know
Express News | AbbVie Shares Are Trading Higher After Multiple Analysts Raised Their Price Targets on the Stock. The Company Last Week Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Adjusted EPS Guidance
Express News | Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $205
Fund Update: KEYBANK NATIONAL ASSOCIATION/OH Just Disclosed New Holdings
Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $250
AbbVie Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and AbbVie (ABBV)
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now